A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy
about
Anemia in inflammatory bowel disease: an under-estimated problem?Pre-operative anaemiaCurrent and potential imaging applications of ferumoxytol for magnetic resonance imaging.Clinical Translation of Nanomedicine.Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic ReviewFerumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemiaRelative Incidence of Acute Adverse Events with Ferumoxytol Compared to Other Intravenous Iron Compounds: A Matched Cohort Study.Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young AdultsSafety and technique of ferumoxytol administration for MRI.Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders.MRI with ferumoxytol: A single center experience of safety across the age spectrumHow we diagnose and treat iron deficiency anemia.Intravenous Ferumoxytol in Pediatric Patients With Iron Deficiency Anemia.What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent.Systematic review and meta-analysis of iron therapy in anaemic adults without chronic kidney disease: updated and abridged Cochrane review.Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions.Reply to McCulley et al., reports to FDA of fatal anaphylaxis associated with intravenous iron products.Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer.Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients.Advances in Magnetic Nanoparticles for Biomedical Applications.MRI monitoring of monocytes to detect immune stimulating treatment response in brain tumor.Correction of iron deficiency anaemia using IV CosmoFer in CKD patients with asthma: a prospective study.Comparative safety of intravenous ferumoxytol vs ferric carboxymaltose in iron deficiency anemia: A randomized trial.Bactericidal and immunomodulatory properties of magnetic nanoparticles functionalized by 1,4-dihydropyridines.Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous ironBiologically Targeted Magnetic Hyperthermia: Potential and Limitations
P2860
Q26860882-B5E22E22-FC14-4584-9980-69CFAF68F1CDQ26998362-D8F50F24-8B8B-4A77-8C00-5698F6E2DCF9Q30234702-6AC8D651-0F85-4698-B0EE-E0450C01B355Q30355939-BEAC7312-FCA9-4CEC-B733-ABA558CCFE06Q35659768-013378E1-AF3B-4EAC-9146-16A8DB4CF97FQ36086930-B4A24E4B-2816-4E81-A1C8-39D19CD00DEBQ36263980-3AA5B8B3-2826-4F4E-ABF3-3FFB3F2D06C0Q36664896-DC3643E5-88BA-4067-B490-9D387C91FAB1Q36862859-7430E706-F8A2-4B93-9E6D-4D7E64B75DE0Q37098701-57F2F3A8-F658-41D2-B7C7-65EE643E1A03Q37622520-CD0D1AE8-DFA2-407F-869F-8C742FB3399DQ38593099-26B67B6F-9580-4FDA-B0A9-0617ED6E920AQ38722040-C59F2C7A-A066-4BE4-AF9B-2CF7D1AF6606Q38790910-20127648-86B9-4BC7-9052-288451E54B70Q38819226-56E9345B-D52A-4D20-9BF2-A8BAD7DFCA19Q39017070-D949EABB-03FB-4ACB-9DDE-A2958DE1A643Q42370571-542ECC6C-DE65-4C60-8585-7AE3C442D521Q45948361-204CA3A4-CBEC-4BCA-AB3E-01C01A2089DEQ47137741-C518E506-5028-4799-8DBE-7BE3EBD947E1Q47150560-1EEB2BC2-A2DB-4280-943B-A173D1215FD5Q47199588-EF1041FA-F391-444A-AF2C-2C03377E0377Q47216873-C5B29063-EAB3-409D-9A87-EA87A2237E8EQ48544742-2E58593C-1E4F-4234-AB0A-C8DA228530C1Q48787043-ED658C64-52AD-460C-ABFC-20E9306B6045Q50125158-58C1EA82-C83E-4B8D-B1D6-09B56C74B701Q55195803-37C616FF-ACE1-401A-9E71-FE34F0CC8E4CQ58700922-5B200671-C953-41F3-B5D1-6AF86227956CQ58803377-E85E09FC-A4FC-49B9-A5DD-84BDE3E2FB04
P2860
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A Phase III, randomized, open- ...... satisfactory oral iron therapy
@ast
A Phase III, randomized, open- ...... satisfactory oral iron therapy
@en
A Phase III, randomized, open- ...... satisfactory oral iron therapy
@nl
type
label
A Phase III, randomized, open- ...... satisfactory oral iron therapy
@ast
A Phase III, randomized, open- ...... satisfactory oral iron therapy
@en
A Phase III, randomized, open- ...... satisfactory oral iron therapy
@nl
prefLabel
A Phase III, randomized, open- ...... satisfactory oral iron therapy
@ast
A Phase III, randomized, open- ...... satisfactory oral iron therapy
@en
A Phase III, randomized, open- ...... satisfactory oral iron therapy
@nl
P2093
P2860
P356
P1476
A Phase III, randomized, open- ...... satisfactory oral iron therapy
@en
P2093
Audrone Urboniene
David Hetzel
Kristine Bernard
Lee F Allen
William Strauss
P2860
P304
P356
10.1002/AJH.23712
P577
2014-06-01T00:00:00Z